Entellus Medical (ENTL) Tops Q3 EPS by 36c

November 1, 2017 4:15 PM

Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of ($0.13), $0.36 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $23.27 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.


Earnings Guidance